SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-018520
Filing Date
2016-11-14
Accepted
2016-11-14 17:24:23
Documents
72
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0916_dandritbiotech.htm 10-Q 479377
2 CERTIFICATION f10q0916ex31i_dandritbiotech.htm EX-31.1 10118
3 CERTIFICATION f10q0916ex32i_dandritbiotech.htm EX-32.1 5530
  Complete submission text file 0001213900-16-018520.txt   3735761

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ddrt-20160930.xml EX-101.INS 603613
5 XBRL SCHEMA FILE ddrt-20160930.xsd EX-101.SCH 45273
6 XBRL CALCULATION FILE ddrt-20160930_cal.xml EX-101.CAL 55557
7 XBRL DEFINITION FILE ddrt-20160930_def.xml EX-101.DEF 156608
8 XBRL LABEL FILE ddrt-20160930_lab.xml EX-101.LAB 412287
9 XBRL PRESENTATION FILE ddrt-20160930_pre.xml EX-101.PRE 294891
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 161995997
SIC: 2834 Pharmaceutical Preparations